<DOC>
	<DOCNO>NCT02075047</DOCNO>
	<brief_summary>The purpose study determine ziprasidone safe effective treatment child adolescent ( age 10-17 ) bipolar I disorder ( manic mixed ) .</brief_summary>
	<brief_title>Efficacy Safety Trial Flexible Doses Oral Ziprasidone Children Adolescents With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>DSM V criterion Bipolar I disorder ( manic mixed ) ; age 10 17 year . Imminent risk suicide homicide , judge site investigator ; history serious unstable medical illness , include risk QT prolongation .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar I Disorder ( current recent episode manic ) . Children adolescent age 10 17 year .</keyword>
</DOC>